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During the period of December 2004 to January 2005, Bacillus anthracis killed three wild chimpanzees 
(Pan troglodytes troglodytes) and one gorilla (Gorilla gorilla gorilla) in a tropical forest in Cameroon. 
While this is the second anthrax outbreak in wild chimpanzees, this is the first case of anthrax in 
gorillas ever reported. The number of great apes in Central Africa is dramatically declining and the 
populations are seriously threatened by diseases, mainly Ebola. Nevertheless, a considerable number 
of deaths cannot be attributed to Ebola virus and remained unexplained. Our results show that 
diseases other than Ebola may also threaten wild great apes, and indicate that the role of anthrax in 
great ape mortality may have been underestimated. These results suggest that risk identification, 
assessment, and management for the survival of the last great apes should be performed with an 
open mind, since various pathogens with distinct characteristics in epidemiology and pathogenicity 
may impact the populations. An animal mortality monitoring network covering the entire African tropical 
forest, with the dual aims of preventing both great ape extinction and human disease outbreaks, will 





Ebola virus has had a devastating effect on the Central African great ape populations of Gabon and 
the Republic of Congo (RC) [Leroy et al., 2004; Walsh et al., 2003], where 80% of Africa’s remaining 
gorillas and chimpanzees are found. Gorilla and chimpanzee densities are estimated to have fallen by 
at least 90% between 1994 and 1996 throughout Minkebe Forest, which is located in northeastern 
Gabon close to the border with Cameroon [Huijbregts et al., 2003]. Likewise, great ape populations 
are estimated to have declined by up to 80% in the Gabon/RC border region between 2001 and 2003 
[Leroy et al., 2004]. However, not all dead apes available for testing have tested positive for Ebola, 
raising the concerns that other pathogens may also be involved in this substantial die-off. 
 
During the period of December 2004 and January 2005, three chimpanzees (Pan troglodytes 
troglodytes) and one gorilla (Gorilla gorilla gorilla) carcasses were recovered within a 35-km2 area at 
the northern border of the Dja Biosphere Reserve, a Cameroonian forest region adjacent to Minkebe 
Forest (Table I).  
 
Bone and muscle samples were tested for various pathogens by the Great Ape Health Monitoring Unit 
(GAHMU) and the Centre International de Recherches Médicales de Franceville (CIRMF). In a highly 
sensitive and specific real-time PCR assay (for detailed methodology see Ellerbrok et al. [2002]), all 
  
four animals tested positive for the Bacillus anthracis-specific virulence genes cap and pag, as well as 
for the chromosomal rpoB gene. 
 
 
Materials and Methods 
 
Since mortality in wild great apes can be caused by a variety of pathogens, identification of these 
pathogens requires a broad approach, including analyses for the various pathogens that may have 
caused death. Since Ebola virus has had a major impact on the great apes of a nearby region, this 
pathogen was analyzed first, followed by a variety of other tests, including real-time PCR assays for B. 
anthracis, Orthopox viruses, Yersinia pestis, and Francisella tularensis, and a general screening for a 
broad spectrum of bacteria using a PCR based on the highly conserved 16S rDNA region of the 
bacterial genome, followed by cloning and sequencing. 
 
 
DNA and RNA Extraction and PCR 
 
For analyses at the Robert Koch Institute (RKI), bone samples were available from the gorilla and two 
of the chimpanzees, as well as muscle tissue from the third chimpanzee that was preserved in RNA-
later (Qiagen, Hilden, Germany; Table I). The bones were cleaned and disinfected from the outside, 
and transferred into a new glove box for sample preparation. Bone marrow and the muscle sample 
were extracted and DNA was prepared with the DNeasy tissue kit (Qiagen). The samples were tested 
by real-time PCR for various pathogens, including B. anthracis, using three different real-time PCRs 
targeting the pag and capC genes encoded by plasmids pXO1 and pXO2, respectively, and the 
chromosomal rpoB gene (see Ellerbrok et al. [2002] for details). Plasmids pXO1 and pXO2 both have 
to be present in pathogenic B. anthracis [Ellerbrok et al., 2002; Hill et al., 2004; Koehler 2002]. They 
can therefore be used to differentiate virulent B. anthracis from apathogenic variants and the 
closelyrelated species B. cereus, B. thuringiensis, and B. megaterium [Ellerbrok et al., 2002]. 
Amplification was performed in two independent replicates for each sample.  
 
All specimens for Ebola testing were taken and manipulated at the BSL4 laboratory of the Centre 
International de Recherches Médicales de Franceville (CIRMF) in Gabon, according to World Health 
Organization (WHO) guidelines on the screening of viral hemorrhagic fever agents in Africa. Total 
RNA was extracted from the bone marrow and the muscle sample from all four great ape samples 
available, first-strand cDNA was synthesized, and cDNA was amplified as previously described [Leroy 
et al., 2004]. The methods used to detect Ebola virus antigens and immunohistochemical staining 





All samples from the three chimpanzees and one gorilla analyzed at the RKI were clearly positive for 
anthrax in all three PCR assays, and negative for the other pathogens analyzed, including Ebola, 
which was tested at the CIRMF, Gabon. It is worth noting that since 2001 samples of muscle and skin 
tissue from 15 other well-preserved great ape carcasses have been tested for Ebola at the CIRMF. Of 
these, nine animals tested positive, and all of these were discovered during the human Ebola 
outbreaks that occurred between 2001 and 2003 [World Health Organization, 2004]. Six well-
preserved carcasses tested negative for Ebola. However, none of the Ebola-negative samples tested 
at CIRMF remain for further investigation, and therefore could not be tested for B. anthracis. 
 
These findings indicate that in addition to Ebola, anthrax accounts for mortalities in wild great apes. 
Additionally, there remain a number of unexplained deaths for which respiratory diseases, measles, or 
other pathogens may be responsible [Leendertz et al., in press; Wolfe et al., 1998] and the cause of 










This is the second reported outbreak of anthrax in wild chimpanzees following the original report of 
anthrax in chimpanzees from the Taï Forest in Côte d’Ivoire [Leendertz et al., 2004]. Furthermore, this 
represents the first recorded case of anthrax in gorillas, and it is the first time that anthrax has been 
detected simultaneously in Central African chimpanzees and gorillas. The detection of anthrax in 
chimpanzees and gorillas from two different regions of African tropical rainforest, a habitat with 
extremely low visibility, may indicate that a large number of victims have not yet been discovered. This 
suggests that the role of anthrax in great ape mortality may have been underestimated.  
 
B. anthracis is not normally transmitted from one animal to another; the epidemiology of infection is 
usually linked to a particular source [e.g., Beatty et al., 2003; Lindeque & Turnbull, 1994], such as 
contaminated ground (grass) that is consumed by grazing animals, contaminated water, or the meat of 
other anthrax victims consumed by scavengers and humans. In addition, there are two significant 
presentations of anthrax: cutaneous and respiratory [Jensen et al., 2003]. Briefly, cutaneous anthrax is 
a less lethal form that results from infections in open wounds and has a local manifestation. 
Respiratory anthrax is highly lethal and has recently garnered attention because of bioterrorist acts, an 
accidental release from a bio-weapons facility, and accidents in the leather industry [Abramova et al., 
1993; Jackson et al., 1998; Lane et al., 2001]. This form has not been described in natural settings.  
 
The epidemiology shows that in contrast to diseases that spread easily from one animal to another 
(e.g., Ebola virus, measles, respiratory diseases, and many others) anthrax does not have the 
potential to cause progressive outbreaks. However, areas that are largely contaminated with spores of 
B. anthracis may still cause significant concern to the local human population because spores of B. 
anthracis are highly resistant in the environment and can survive hundreds of years in the ground 
[Jensen et al., 2003]. 
 
To avoid contamination of areas that have no history of anthrax outbreaks, an appropriate 
preventative risk management plan is required. This may include hygienic barriers around the 
protected area, including the disinfection of tires before vehicles enter the protected area. Because of 
the frequency of anthrax outbreaks involving domestic ruminants, farming close to park boundaries 
should be prohibited. Additionally, a detailed monitoring program is required to assess the presence of 
the pathogen in protected areas.  
 
Such monitoring is most practical when it is based on systematic mortality monitoring and the 
collection of samples from carcasses. In addition, noninvasive sampling from live animals (feces and 
urine) can be performed and used for specific analyses. A major constraint hampering the systematic 
collection of samples from carcasses and live animals is that in remote areas refrigeration is frequently 
unavailable, and thus cool chains cannot be maintained. However, recently developed methods 
enable samples to be stored without special requirements, such as cooling [Leendertz et al., in press]. 
These methods could open up new possibilities for epidemiological studies, even in areas with no 
infrastructure, and may significantly enhance our understanding of mortality in wildlife [Leendertz et al., 
in press].  
 
Because of the physiological and genetic similarities between humans and great apes, human 
pathogens can be easily transmitted to great apes, resulting in their death [Ferber, 2000; Wallis, 2000; 
Woodford et al., 2002]. Therefore, collected samples should be tested for a variety of pathogens, 
including human pathogens, especially in areas where great apes are found in close proximity to 
human beings (e.g., great ape research camps and tourism sites).  
 
The results of such a broad pathogen monitoring program may allow the assessment of risk factors 
and form the basis of an appropriate risk-assessment plan. 
 
Existing countermeasures can then be reevaluated while taking into account the epidemiology of all of 
the important pathogens found in a certain region, including pathogens that may pose a substantial 
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Table 1 Carcasses Found at the Northern Periphery of the Dja Reserve Cameroon* 
 
 
*Corresponding samples tested negative for Ebola by the CIRMF. All samples were also negative for 
Orthopox virus, Yersinia, Francisella and others. n.d, no data, only rough description available; Pos, 
positive; Neg, negative results from PCR testing. 
  
